Original Research
Published on 31 Mar 2022
N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.730530
- 2,721 views
- 6 citations
Type at least 3 characters
1,768 articles
Articles
Original Research
Published on 31 Mar 2022
The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.829705
- 3,750 views
- 8 citations
Original Research
Published on 30 Mar 2022
A Panel of Bile Volatile Organic Compounds Servers as a Potential Diagnostic Biomarker for Gallbladder Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.858639
- 3,038 views
- 6 citations
Review
Published on 28 Mar 2022
Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.848221
- 4,342 views
- 15 citations
Original Research
Published on 25 Mar 2022
A Comprehensive Analysis of the Glutathione Peroxidase 8 (GPX8) in Human Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.812811
- 10,097 views
- 20 citations
Review
Published on 25 Mar 2022
Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.780650
- 6,335 views
- 15 citations
Review
Published on 25 Mar 2022
Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.837233
- 5,107 views
- 5 citations
Review
Published on 25 Mar 2022
Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.831949
- 9,925 views
- 30 citations
Review
Published on 24 Mar 2022
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.819128
- 46,141 views
- 315 citations
Original Research
Published on 24 Mar 2022
RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.826617
- 4,844 views
- 6 citations
Original Research
Published on 24 Mar 2022
Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.812560
- 2,910 views
- 3 citations
Original Research
Published on 24 Mar 2022
Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.654449
- 6,047 views
- 15 citations
Original Research
Published on 24 Mar 2022
Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.824594
- 3,383 views
- 4 citations
Mini Review
Published on 24 Mar 2022
Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.746030
- 7,573 views
- 24 citations
Review
Published on 23 Mar 2022
Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.808475
- 4,746 views
- 7 citations
Original Research
Published on 22 Mar 2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1low Mice
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.853484
- 4,531 views
- 11 citations